CVRx, Inc. operates under the executive leadership of Mr. Kevin Hykes, who serves as the President, Chief Executive Officer, and member of the Board of Directors. Bringing extensive medical device industry experience spanning decades of commercializing novel cardiovascular and neuromodulation therapies—including prior executive roles at high-growth medical technology enterprises—he directs the company's corporate strategy, global clinical trials, and commercial expansion of the Barostim system.